Nigeria could soon host Africa’s first insulin production facility, a move experts say would transform diabetes care, cut reliance on costly imports, and position the country as a biotechnology hub.
The project, to be powered by Chinese investment and technology, aims to fill a critical gap in Africa’s healthcare system. With the continent almost entirely dependent on imported insulin, patients often face high costs, shortages, and late access to treatment.
Chinese Ambassador to Nigeria, Yu Dunhai, revealed the plan in Abuja during a reception marking the 76th anniversary of the founding of the People’s Republic of China.
“Chinese companies are in talks with Nigeria to build Africa’s first local insulin production facility, potentially ending Nigeria’s reliance on imported insulin and positioning Nigeria as a hub for African medical biotechnology,” Yu said.
Health experts say local production would drive down costs, ensure steady supply, and reduce diabetes-related complications. It could also stimulate a pharmaceutical value chain, create jobs, and open export opportunities to neighbouring countries.
Yu also spoke of the deepening China–Nigeria relationship, citing projects like the Abuja Water Supply initiative and symbolic ties such as both nations sharing October 1 as their national day.
Nigeria’s Deputy Senate President, Barau Jibrin, who conveyed President Bola Tinubu’s goodwill message, praised China’s role in infrastructure and trade, while pledging Nigeria’s commitment to partnerships that deliver tangible results.
If successful, the insulin plant would mark a major step in Africa’s healthcare independence and strengthen Nigeria’s role in the region’s biotech future
Leave a Reply